Akutt myelogen leukemi
dc.contributor.author | Stavem, Per | en |
dc.contributor.author | Hjort, Peter Fredrik | en |
dc.date.accessioned | 2011-04-01T14:45:27Z | nb_NO |
dc.date.accessioned | 2016-02-08T14:18:27Z | |
dc.date.available | 2011-04-01T14:45:27Z | nb_NO |
dc.date.available | 2016-02-08T14:18:27Z | |
dc.date.issued | 1968-11-01 | nb_NO |
dc.identifier.citation | Tidsskrift for den Norske lægeforening 1968, 88 (21):2030 | en |
dc.identifier.issn | 0029-2001 | nb_NO |
dc.identifier.uri | http://hdl.handle.net/11250/2377486 | |
dc.language | nor | nb_NO |
dc.language.iso | nob | en |
dc.subject | VDP::Medisinske Fag: 700::Klinisk medisinske fag: 750::Hematologi: 775 | en |
dc.subject.mesh | Adult | en |
dc.subject.mesh | Antineoplastic Agents | en |
dc.subject.mesh | Humans | en |
dc.subject.mesh | Leukemia, Myeloid, Acute | en |
dc.subject.mesh | myeloblaster | en |
dc.subject.mesh | benmargen | en |
dc.subject.mesh | steroider | en |
dc.subject.mesh | lymfeknutesvulst | en |
dc.title | Akutt myelogen leukemi | no |
dc.title.alternative | Acute myelogenous leukemia | en |
dc.type | Journal article | en |
dc.type | Peer reviewed | en |
dc.source.journal | Tidsskrift for den Norske lægeforening | en |
dc.identifier.pmid | 5248052 | nb_NO |